Vital Art and Science, a Richardson, TX-based developer of a home vision monitor, completed a $550k Series A financing round.
The round, which was led by the North Texas Angel Network (NTAN), valued the company at $10m (post financing).
Vital Art and Science intends to use the funds to continue development and increase adoption of its products.
Founded in 2006 by President Mike Bartlett, the company provides smart phone-based home monitor products. Its myVisionTrack is a test for patients diagnosed with a wet-AMD or diabetic retinopathy to monitor their disease progress and help ensure they get timely treatments. It can be used in a physician’s office or at home by patients to help track disease progression, detect disease condition changes for earlier intervention and document treatment effects.